JP2002308895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002308895A5 JP2002308895A5 JP2002026232A JP2002026232A JP2002308895A5 JP 2002308895 A5 JP2002308895 A5 JP 2002308895A5 JP 2002026232 A JP2002026232 A JP 2002026232A JP 2002026232 A JP2002026232 A JP 2002026232A JP 2002308895 A5 JP2002308895 A5 JP 2002308895A5
- Authority
- JP
- Japan
- Prior art keywords
- angstroms
- rays
- irradiation
- wavelength
- copper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013078 crystal Substances 0.000 claims 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 4
- 229910052802 copper Inorganic materials 0.000 claims 4
- 239000010949 copper Substances 0.000 claims 4
- 238000000634 powder X-ray diffraction Methods 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 2
- 238000002425 crystallisation Methods 0.000 claims 2
- 230000008025 crystallization Effects 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002026232A JP3748536B2 (ja) | 2001-02-09 | 2002-02-04 | ピリミジンヌクレオシド誘導体の結晶 |
| US10/637,300 US6908906B2 (en) | 2001-02-09 | 2003-08-07 | Crystalline forms of pyrimidine nucleoside derivative |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001033128 | 2001-02-09 | ||
| JP2001-33128 | 2001-02-09 | ||
| JP2002026232A JP3748536B2 (ja) | 2001-02-09 | 2002-02-04 | ピリミジンヌクレオシド誘導体の結晶 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005230800A Division JP4356998B2 (ja) | 2001-02-09 | 2005-08-09 | ピリミジンヌクレオシド誘導体の結晶を含有する医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002308895A JP2002308895A (ja) | 2002-10-23 |
| JP2002308895A5 true JP2002308895A5 (enExample) | 2005-08-18 |
| JP3748536B2 JP3748536B2 (ja) | 2006-02-22 |
Family
ID=18896929
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002026232A Expired - Lifetime JP3748536B2 (ja) | 2001-02-09 | 2002-02-04 | ピリミジンヌクレオシド誘導体の結晶 |
| JP2005230800A Expired - Lifetime JP4356998B2 (ja) | 2001-02-09 | 2005-08-09 | ピリミジンヌクレオシド誘導体の結晶を含有する医薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005230800A Expired - Lifetime JP4356998B2 (ja) | 2001-02-09 | 2005-08-09 | ピリミジンヌクレオシド誘導体の結晶を含有する医薬 |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1364959B1 (enExample) |
| JP (2) | JP3748536B2 (enExample) |
| KR (1) | KR100679904B1 (enExample) |
| CN (1) | CN100408591C (enExample) |
| AT (1) | ATE361929T1 (enExample) |
| AU (1) | AU2002230164B2 (enExample) |
| BR (2) | BR0207102A (enExample) |
| CA (1) | CA2437994C (enExample) |
| CY (1) | CY1106685T1 (enExample) |
| CZ (1) | CZ303241B6 (enExample) |
| DE (1) | DE60220024T2 (enExample) |
| DK (1) | DK1364959T3 (enExample) |
| ES (1) | ES2286237T3 (enExample) |
| HU (1) | HU229294B1 (enExample) |
| IL (2) | IL157216A0 (enExample) |
| MX (1) | MXPA03007123A (enExample) |
| NZ (1) | NZ527393A (enExample) |
| PT (1) | PT1364959E (enExample) |
| RU (1) | RU2256666C2 (enExample) |
| WO (1) | WO2002064609A1 (enExample) |
| ZA (1) | ZA200306121B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2081419B1 (en) | 1999-09-02 | 2013-08-07 | Ibiden Co., Ltd. | Printed circuit board and method of manufacturing printed circuit board |
| CN101232776B (zh) | 1999-09-02 | 2011-04-20 | 揖斐电株式会社 | 印刷布线板 |
| GB0526419D0 (en) * | 2005-12-23 | 2006-02-08 | Cyclacel Ltd | Formulation |
| GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
| JP5066737B2 (ja) * | 2007-04-06 | 2012-11-07 | 大鵬薬品工業株式会社 | シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤 |
| US8124593B2 (en) | 2007-11-05 | 2012-02-28 | Cyclacel Limited | Methods of treatment using sapacitabine |
| GB0808357D0 (en) | 2008-05-08 | 2008-06-18 | Cyclacel Ltd | Process |
| CA2725295C (en) | 2008-06-09 | 2016-11-08 | Cyclacel Limited | Combination of sapacitabine (cndac) and dna methyltransferase inhibitors such as decitabine and procaine |
| US10226478B2 (en) | 2011-04-14 | 2019-03-12 | Cyclacel Limited | Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia |
| CN108658873B (zh) * | 2012-03-15 | 2021-09-14 | 西建卡尔有限责任公司 | 表皮生长因子受体激酶抑制剂的固体形式 |
| JP7236215B2 (ja) * | 2015-03-09 | 2023-03-09 | ダブリュー・アール・グレース・アンド・カンパニー－コーン | ニコチンアミドリボシドの結晶形 |
| EP3727400A4 (en) | 2017-12-22 | 2021-10-20 | Elysium Health, Inc. | CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2559917B2 (ja) * | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
| RU2085557C1 (ru) * | 1991-09-30 | 1997-07-27 | Санкио Компани Лимитед | Производные нуклеозидов пиримидина или их фармацевтически приемлемые соли и способ их получения |
-
2002
- 2002-02-04 JP JP2002026232A patent/JP3748536B2/ja not_active Expired - Lifetime
- 2002-02-06 EP EP02711347A patent/EP1364959B1/en not_active Expired - Lifetime
- 2002-02-06 MX MXPA03007123A patent/MXPA03007123A/es active IP Right Grant
- 2002-02-06 CN CNB028079337A patent/CN100408591C/zh not_active Expired - Lifetime
- 2002-02-06 RU RU2003124648/04A patent/RU2256666C2/ru active
- 2002-02-06 CZ CZ20032111A patent/CZ303241B6/cs not_active IP Right Cessation
- 2002-02-06 IL IL15721602A patent/IL157216A0/xx active IP Right Grant
- 2002-02-06 DK DK02711347T patent/DK1364959T3/da active
- 2002-02-06 AT AT02711347T patent/ATE361929T1/de active
- 2002-02-06 AU AU2002230164A patent/AU2002230164B2/en not_active Expired
- 2002-02-06 KR KR1020037010308A patent/KR100679904B1/ko not_active Expired - Lifetime
- 2002-02-06 NZ NZ527393A patent/NZ527393A/en not_active IP Right Cessation
- 2002-02-06 DE DE60220024T patent/DE60220024T2/de not_active Expired - Lifetime
- 2002-02-06 CA CA2437994A patent/CA2437994C/en not_active Expired - Lifetime
- 2002-02-06 ES ES02711347T patent/ES2286237T3/es not_active Expired - Lifetime
- 2002-02-06 BR BR0207102-9A patent/BR0207102A/pt not_active Application Discontinuation
- 2002-02-06 HU HU0303159A patent/HU229294B1/hu unknown
- 2002-02-06 BR BRPI0207102A patent/BRPI0207102A8/pt unknown
- 2002-02-06 PT PT02711347T patent/PT1364959E/pt unknown
- 2002-02-06 WO PCT/JP2002/000986 patent/WO2002064609A1/ja not_active Ceased
-
2003
- 2003-08-04 IL IL157216A patent/IL157216A/en unknown
- 2003-08-07 ZA ZA2003/06121A patent/ZA200306121B/en unknown
-
2005
- 2005-08-09 JP JP2005230800A patent/JP4356998B2/ja not_active Expired - Lifetime
-
2007
- 2007-07-02 CY CY20071100860T patent/CY1106685T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023145481A5 (enExample) | ||
| JP2002308895A5 (enExample) | ||
| JP2018024682A5 (enExample) | ||
| JP2011168587A5 (enExample) | ||
| JP2020511467A5 (enExample) | ||
| DE60325074D1 (de) | Kristall für ein orales, festes arzneimittel, und ein orales, festes arnzeimittel zur behandlung von dysurie, das diesen enthält | |
| WO2004004648A3 (en) | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use | |
| JP2021502388A5 (enExample) | ||
| DK1356835T3 (da) | Låsemekanisme til kirurgisk kassette | |
| ATE545630T1 (de) | Kristallform des kaliumsalzes von (2r,4r)-monatin und diese enthaltende süssmittelzusammensetzung | |
| JP2008506632A5 (enExample) | ||
| KR970027079A (ko) | (r)-(-)-2-{n-[4-(1,1-디옥시도-3-옥소-2,3-디히드로-벤즈이소티아졸-2-일)-부틸]-아미노메틸}-크로만의 결정성 염산염 | |
| JP2004188187A5 (enExample) | ||
| IS7965A (is) | Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi | |
| AR029571A1 (es) | Nueva forma cristalina beta de la sal de terbutilamina de perindopril, procedimiento para su preparacion y composiciones farmaceuticas que la contienen | |
| AU2002351240A1 (en) | Gold nanoparticles used for x-rays imaging | |
| JP2005511612A5 (enExample) | ||
| JP2007191765A5 (enExample) | ||
| JP2004510683A5 (enExample) | ||
| JP2005509503A5 (enExample) | ||
| JP2006502115A5 (enExample) | ||
| ES2422730T3 (es) | Sales de tiotropio, procedimiento para su preparación, así como formulaciones de medicamentos que las contienen | |
| RU99104300A (ru) | Кристаллическая модификация фармацевтического агента | |
| CU23200A3 (es) | Sal polimorfica | |
| CA2437994A1 (en) | Crystalline forms of pyrimidine nucleoside derivative |